HEC CJ PHARM: JOINT ANNOUNCEMENT MONTHLY UPDATE PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE IN RELATION TO THE POSSIBLE MERGER OF THE COMPANY
HEC CJ PHARM: EXCHANGE NOTICE - RESUMPTION OF TRADING
HEC CJ PHARM: INSIDE INFORMATION IN RELATION TO A POSSIBLE TRANSFER OF SHARES IN THE COMPANY UNUSUAL PRICE MOVEMENTS ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE AND INSIDE INFORMATION IN RELATION TO A POSSIBLE MERGER OF THE COMPANY AND RESUMPTI
HEC CJ PHARM: TRADING HALT
HEC CJ PHARM: EXCHANGE NOTICE - TRADING HALT
HEC PHARM: CHANGE OF STOCK SHORT NAME
HEC PHARM: 2022 Report of the Board of Directors 2022 Report of the Board of Supervisors 2022 Consolidated Financial Statements 2022 Annual Report Re-appointment of the Auditor of the Company Renewal of the General Mandate to Issue Shares and Repurchase H
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION PLEDGE OF SHARES BY CONTROLLING SHAREHOLDER
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION UPDATE ON SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION PLEDGE OF SHARES BY CONTROLLING SHAREHOLDER
YiChang HEC ChangJiang Pharmaceutical: 2021 Report of the Board of Directors 2021 Report of the Board of Supervisors 2021 Consolidated Financial Statements 2021 Annual Report Re-appointment of the Auditor of the Company Adjustment of the Remuneration of an
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION UPDATE ON SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION UPDATE ON SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION UPDATE ON POSSIBLE SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION UPDATE ON POSSIBLE SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: INSIDE INFORMATION POSSIBLE SHARE TRANSFER BY CONTROLLING SHAREHOLDER OF THE COMPANY
YiChang HEC ChangJiang Pharmaceutical: 2019 REPORT OF THE BOARD OF DIRECTORS, 2019 REPORT OF THE BOARD OF SUPERVISORS, 2019 CONSOLIDATED FINANCIAL STATEMENTS, 2019 ANNUAL REPORT, PROPOSED BONUS ISSUE AND PROPOSED DISTRIBUTION OF 2019 FINAL DIVIDEND, PROPO
YiChang HEC ChangJiang Pharmaceutical: 2018 REPORT OF THE BOARD OF DIRECTORS, 2018 REPORT OF THE BOARD OF SUPERVISORS, 2018 CONSOLIDATED FINANCIAL STATEMENTS, 2018 ANNUAL REPORT, 2018 PROFITS DISTRIBUTION PLAN, RE-APPOINTMENT OF THE AUDITOR OF THE COMPANY
No Data